Fertility-Preserving Cancer Surgery: 8 Questions to Ask Before Saying Yes

The short answer: some younger women with an early cancer of the cervix, ovary or womb can have treatment that keeps the womb or one ovary, so that pregnancy may still be possible later. It is safe only for selected small, early, low-grade cancers, and a pregnancy cannot be guaranteed. The decision has to be made before standard surgery or chemotherapy, so say at your first appointment if you hope to have children. Below are 8 questions worth asking before you agree to it.

Many families search for this as kya cancer ke baad maa ban sakte hain (क्या कैंसर के बाद माँ बन सकते हैं). Take these questions with you; our guide to preparing for a specialist appointment lists the reports to bring.

On this page

• Question 1: Am I medically eligible for fertility-preserving surgery?
• Question 2: What is the oncological safety vs standard surgery?
• Question 3: What is the realistic pregnancy success rate after this surgery?
• Question 4: What surveillance is required afterwards?
• Question 5: When can I attempt pregnancy after surgery?
• Question 6: What happens if cancer recurs?
• Question 7: Will the surgeon perform definitive surgery later if I complete my family?
• Question 8: What is the cost difference compared with standard surgery?
• FAQs

Question 1: Am I medically eligible for fertility-preserving surgery?

Eligibility is strict. It depends on the type of cancer and its size, stage and grade. In general:

• Cervical cancer (bachedani ke muh ka cancer): the very smallest cancers (stage IA1) may be treated with a cone biopsy; selected stage IA2–IB1 cancers 2 cm or smaller, with no spread to the lymph nodes, may be suitable for a radical trachelectomy (removing the cervix and the tissue around it but keeping the womb).
• Ovarian cancer: selected stage IA cancers of a favourable type, confined to one ovary, after careful staging surgery.
• Womb (endometrial) cancer: grade 1 endometrioid cancer that has not grown into the womb muscle (no myometrial invasion) on MRI, treated with hormones (progestogens) and close checks instead of a hysterectomy.

Outside these limits, keeping the womb or ovary can lower the chance of cure. Ask which of your reports (biopsy, MRI, lymph node results) makes you eligible or not.

Question 2: What is the oncological safety vs standard surgery?

For carefully selected women with small, early, low-grade cancers that have been fully staged, results are similar to standard surgery. For larger, high-grade or more advanced cancers the risk is higher, which is why this is not offered to everyone. The most important question is whether you, specifically, meet the criteria.

For cervical cancer, also ask whether the trachelectomy will be done as open or keyhole (laparoscopic or robotic) surgery. A large 2018 study (the LACC trial) found worse survival with keyhole and robotic radical hysterectomy than with open surgery, so for a radical trachelectomy the approach is chosen carefully and open surgery is often preferred. The robot is not automatically the better choice.

Question 3: What is the realistic pregnancy success rate after this surgery?

Pregnancy is possible, but it is not guaranteed. After a radical trachelectomy, published results vary widely. In a 2020 review of more than 2,500 women, about 1 in 4 of all the women had a pregnancy afterwards (not all of them were trying to conceive), and about 3 in 4 of those pregnancies ended in a live birth. Miscarriage and early (preterm) birth are more common than usual, so these pregnancies need specialist obstetric care, and the baby is delivered by planned caesarean section. Your own chance also depends on your age and other fertility factors, so ask for an honest estimate for your situation.

Question 4: What surveillance is required afterwards?

Follow-up is closer than after standard surgery. Check-ups are usually every 3 months for the first 2 years, then every 6 months up to year 5, with an examination and scans or tests when needed. After hormone treatment for early womb cancer, a repeat biopsy is usually taken about every 3 months. Late recurrence is uncommon but possible, so keeping every follow-up appointment is essential.

Question 5: When can I attempt pregnancy after surgery?

It depends on the treatment. After a trachelectomy, many teams advise waiting several months, often about 6–12 months, so that healing is complete and the first check-ups are clear. After hormone treatment for early womb cancer, pregnancy is usually attempted once biopsies show the cancer has gone, and fertility treatment may be suggested to avoid delay. Ask your team when it is safe for you to start trying.

Question 6: What happens if cancer recurs?

Treatment depends on the type of cancer and where it comes back. It may include surgery to remove the womb (and the ovaries for some cancers), chemoradiation (radiotherapy, or sikai, with chemotherapy) or chemotherapy. Regular follow-up aims to find any return early, when more treatment options are available.

Question 7: Will the surgeon perform definitive surgery later if I complete my family?

It depends on the cancer. After hormone treatment for early womb cancer, a hysterectomy is usually advised once your family is complete. After ovary-sparing surgery for ovarian cancer, removing the remaining ovary and the womb is recommended in most cases once childbearing is complete. After a trachelectomy, whether a later hysterectomy is needed is decided individually. Discuss the likely timing before your first operation.

Question 8: What is the cost difference compared with standard surgery?

The cost depends on the operation, the approach (open, keyhole or robotic), the hospital and the length of stay, so ask the hospital where the surgery will be done for a written estimate. Also plan for closer follow-up, any egg or embryo freezing, and later specialist pregnancy care with a caesarean delivery.

For full detail on who is eligible and the limits, see fertility-preserving surgery in selected patients, Stage 1 cervical cancer fertility-sparing, early endometrial fertility-sparing.

FAQs

Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. To book: WhatsApp +91 76988 00333.